KWALITY PHARMACEUTICALS
|
The Current P/S Ratio of KWALITY PHARMACEUTICALS is 2.21.
| Share Price | ₹896.3 | Dec 10,2025 |
| Market Cap | ₹932.2 Cr | |
| Sales-TTM | ₹422.6 Cr | TTM-Consolidated Results |
| Price/Sales | 2.21x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of KWALITY PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹932.2 Cr] as on Dec 10,2025
(/) Sales [ ₹422.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.21x ]
Thus, for KWALITY PHARMACEUTICALS , the investors are currently willing to pay '2.21 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KWALITY PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of KWALITY PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of KWALITY PHARMACEUTICALS
PS Ratio Performance Analysis for KWALITY PHARMACEUTICALS
- KWALITY PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.33x.
- KWALITY PHARMACEUTICALS 's operated at median p/e ratio of 1.32x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KWALITY PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 2.44x.
- KWALITY PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 0.22x.
How does KWALITY PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| KWALITY PHARMACEUTICALS | 422.6 | 2.21 | 932.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.80 | 428,581.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.66 | 167,051.0 |
| CIPLA LTD | 28,349.6 | 4.24 | 120,289.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.48 | 128,367.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.04 | 104,421.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.53 | 88,649.9 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.79 | 92,945.8 |
| LUPIN LTD | 24,750.7 | 3.79 | 93,866.9 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.09 | 68,035.1 |
| ABBOTT INDIA LTD | 6,714.4 | 8.87 | 59,563.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KWALITY PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.09x |
| Max industry PS | 16.66x |
| Median industry PS | 4.24x |
| Average industry PS | 6.32x |
You may also like the below Video Courses